1 min to read News Posted on June 29, 2023 Biotech firm Tevogen Bio enters $1.2 bln SPAC deal for US listing – Reuters Biotech firm Tevogen Bio enters $1.2 bln SPAC deal for US listing reuters Source: Biotech firm Tevogen Bio enters .2 bln SPAC deal for US listing – Reuters share tweet share Tags: SPACs